Fundraising Fox

Stämm

5 known investors

Stämm develops a high-throughput bioprocessor for biomanufacturing, offering hardware for biologics production in research-use settings. It serves research and biopharmaceutical teams working on biologics.

BiotechDeep TechHardware

Investors · 5

AIR CapitalBuenos Airesvia Ignacio Peña · inferred
Draper AssociatesSan Mateo · $500K – $5M
Draper CygnusBuenos Aires · $100K – $1M
GRIDXBuenos Aires · $250K
VaranaDenver

In the news

Stämm Secures a Series A round of $17 Millionprnewswire.com · Mar 2022Stämm Biotech Secures $17 Million For Desktop Sized Bioreactorsgreenqueen.com.hk · Mar 2022Stämm Biotech raises $17M in series A for its next-gen, 3D printed bioreactor - IndieBio - #1 in Early Stage Biotechindiebio.co · Mar 2022Stämm Biotech raises $17M to develop desktop 3D printed bioreactor - 3D Printing Industry3dprintingindustry.com · Mar 2022Varana Capital leads $17 Million Round in Stämm Biotech, Joining Draper Associates and Other Current and New Investorsprnewswire.com · Mar 2022Stämm Biotech Raises $17M in Series A Fundingfinsmes.com · Mar 2022

Frequently asked questions

What does Stämm do?
Stämm develops a high-throughput bioprocessor for biomanufacturing, offering hardware for biologics production in research-use settings. It serves research and biopharmaceutical teams working on biologics.
Who are Stämm's investors?
Stämm's investors include AIR Capital, Draper Associates, Draper Cygnus, GRIDX, Varana.